COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results

March 10, 2022



« back to news page